| Design of antiretroviral clinical trials for HIV-1 infected pregnant women and their newborn infants. | |
| | |
MedLine Citation:
|
PMID: 11453614 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Antiretroviral therapy has been highly successful in reducing mother to child transmission of human immunodeficiency virus-1 infection in pregnant women. However, the treatment regimens are intensive, difficult to deliver in less developed countries, and there are limited pharmacology studies addressing critical questions regarding maternal safety and fetal risk. There are currently 3 pharmacologically diverse classes of antiretroviral agents with inadequate information available to define drug disposition necessary to determine appropriate dose regimens and limited data on long-term adverse events. This article summarizes representative clinical studies for selected antiretrovirals that provide a framework for continuing the necessary clinical research to extend successful outcomes in developed countries to human immunodeficiency virus-1 infected pregnant women and infants world-wide and minimize the risk of long-term adverse effects. |
| | |
Authors:
|
J H Rodman |
Related Documents
:
|
7892074 - Phytohemagglutinin-inducible p24 in peripheral blood mononuclear cells as a predictor o... 453084 - Abo hemolytic disease of the newborn. 19693024 - Effect of maternal hiv status on infant mortality: evidence from a 9-month follow-up of... 20607114 - A window into a public program for prevention of mother to child transmission of hiv: e... 22161404 - Early additional food and fluids for healthy breastfed full-term infants. 11087794 - Restless legs syndrome in monozygotic twins: clinical correlates. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review |
Journal Detail:
|
Title: Seminars in perinatology Volume: 25 ISSN: 0146-0005 ISO Abbreviation: Semin. Perinatol. Publication Date: 2001 Jun |
Date Detail:
|
Created Date: 2001-07-16 Completed Date: 2001-12-07 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 7801132 Medline TA: Semin Perinatol Country: United States |
Other Details:
|
Languages: eng Pagination: 170-6 Citation Subset: IM |
Affiliation:
|
Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN 38105-2794, USA. john.rodman@stjude.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acquired Immunodeficiency Syndrome
/
drug therapy*,
prevention & control,
transmission* Anti-HIV Agents / adverse effects*, pharmacokinetics, therapeutic use* Clinical Trials as Topic* Female Fetus / drug effects Humans Infant, Newborn Infectious Disease Transmission, Vertical Pregnancy Pregnancy Complications, Infectious / virology* |
| Grant Support | |
ID/Acronym/Agency:
|
AI-27562/AI/NIAID NIH HHS; AI-32908/AI/NIAID NIH HHS; AI-39191/AI/NIAID NIH HHS; CA-21765/CA/NCI NIH HHS; RR-11126/RR/NCRR NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Anti-HIV Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Antithrombotic therapy during pregnancy.
Next Document: Antidepressants during pregnancy and lactation: defining exposure and treatment issues.